Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AI Infrastructure Acquisition Corp.AIIA · Entity 6330 | Director | September 30, 2025 | October 01, 2025 |
| Jet.AI Inc.OXAC · Entity 8509 | Director · CFO, Treas., Sec'y & Director | August 11, 2021 | August 11, 2021 |
| OXBRIDGE RE HOLDINGS LtdOXBR · Entity 7972 | Director · CFO & Secretary | February 14, 2025 | February 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AI Infrastructure Acquisition Corp.
Report date September 30, 2025 · Filed October 01, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| No securities are beneficially owned.SEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2025-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 F1: The reported ownership does not include any securities of AI Infrastructure Acquisition Corp. held by AIIA Sponsor Ltd., of which the reporting person is an equity holder and a director. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported ownership does not include any securities of AI Infrastructure Acquisition Corp. held by AIIA Sponsor Ltd., of which the reporting person is an equity holder and a director.
Jet.AI Inc.
Report date August 11, 2021 · Filed August 11, 2021
This filing explicitly reported no securities owned.
OXBRIDGE RE HOLDINGS Ltd
Report date February 14, 2025 · Filed February 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 155,030 |
Ending reported balance
After 2025-02-14 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-02-14 · Grant · Acquired 25,000 · Balance 100,050 F1: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan. Row 2 · 2025-02-14 · Exercise / conversion · Acquired 90,000 · Balance 190,050 F2: Represents a "net exercise" of 90,000 outstanding share options. 35,020 shares were withheld by the company for payment of the exercise price at a share price of $5.14. The remaining net 54,980 ordinary shares were issued to, and retained by, the reporting person. Row 3 · 2025-02-14 · Tax withholding · Disposed 35,020 · Balance 155,030 F2: Represents a "net exercise" of 90,000 outstanding share options. 35,020 shares were withheld by the company for payment of the exercise price at a share price of $5.14. The remaining net 54,980 ordinary shares were issued to, and retained by, the reporting person. |
| Share Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2029-03-16 | Direct | 0 |
Reported balance
After 2025-02-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-02-14 · Exercise / conversion · Disposed 90,000 · Balance 0 F2: Represents a "net exercise" of 90,000 outstanding share options. 35,020 shares were withheld by the company for payment of the exercise price at a share price of $5.14. The remaining net 54,980 ordinary shares were issued to, and retained by, the reporting person. |
| Share Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2031-03-02 | Direct | 75,000 |
Reported balance
Holding disclosure · report date 2025-02-14 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 75,000 F3: These share options are currently exercisable and vested in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period. |
| Share Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.06 · Expires 2027-01-20 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2025-02-14 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 10,000 F3: These share options are currently exercisable and vested in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period. |
| Share Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2026-01-16 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2025-02-14 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 10,000 F3: These share options are currently exercisable and vested in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period. |
| Warrants to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2029-03-26 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2025-02-14 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 7,500 F4: Currently exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan.
F2: Represents a "net exercise" of 90,000 outstanding share options. 35,020 shares were withheld by the company for payment of the exercise price at a share price of $5.14. The remaining net 54,980 ordinary shares were issued to, and retained by, the reporting person.
F3: These share options are currently exercisable and vested in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period.
F4: Currently exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2025 Filed Feb 20, 2025 21:04 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | Exercise / conversionShare Options (right to buy) · Derivative | 90,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000897069-25-000331 · form4.xml · derivative · entry 4 TIMOTHY WRENDON · CIK 0001603598 · Director · CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 90,000 shares Expires 2029-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents a "net exercise" of 90,000 outstanding share options. 35,020 shares were withheld by the company for payment of the exercise price at a share price of $5.14. The remaining net 54,980 ordinary shares were issued to, and retained by, the reporting person. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 21:04 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | Tax withholdingOrdinary Shares | 35,020 | $5.14 | $180,002.80 |
DisclosureSEC source: 0000897069-25-000331 · form4.xml · nonDerivative · entry 3 TIMOTHY WRENDON · CIK 0001603598 · Director · CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,030 F2 · kind: Represents a "net exercise" of 90,000 outstanding share options. 35,020 shares were withheld by the company for payment of the exercise price at a share price of $5.14. The remaining net 54,980 ordinary shares were issued to, and retained by, the reporting person. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 21:04 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | Exercise / conversionOrdinary Shares | 90,000 | $2.00 | $180,000.00 |
DisclosureSEC source: 0000897069-25-000331 · form4.xml · nonDerivative · entry 2 TIMOTHY WRENDON · CIK 0001603598 · Director · CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents a "net exercise" of 90,000 outstanding share options. 35,020 shares were withheld by the company for payment of the exercise price at a share price of $5.14. The remaining net 54,980 ordinary shares were issued to, and retained by, the reporting person. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 21:04 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | GrantOrdinary Shares | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-25-000331 · form4.xml · nonDerivative · entry 1 TIMOTHY WRENDON · CIK 0001603598 · Director · CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,050 F1 · kind: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan. F1 · price: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan. Read SEC document |
| March 25, 2024 Filed Apr 16, 2024 21:54 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | GrantOrdinary Shares | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-014905 · ownership.xml · nonDerivative · entry 1 TIMOTHY WRENDON · CIK 0001603598 · Director · CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,050 F1 · kind: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan. F1 · price: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan. Read SEC document |
| March 25, 2024 Filed Apr 17, 2024 22:18 UTC Amendment | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | GrantOrdinary Shares | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-015072 · ownership.xml · nonDerivative · entry 1 TIMOTHY WRENDON · CIK 0001603598 · Director · CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,050 F1 · kind: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan. F1 · price: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 22:23 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | GrantOrdinary Shares | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000831 · doc1.xml · nonDerivative · entry 1 TIMOTHY WRENDON · CIK 0001603598 · Director · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,050 F1 · kind: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan. F1 · price: Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan. Read SEC document |
| March 02, 2021 Filed Apr 13, 2021 16:15 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | GrantShare Options (right to buy) · Derivative | 75,000 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007957 · doc1.xml · derivative · entry 2 TIMOTHY WRENDON · CIK 0001603598 · Controller & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Ordinary Shares · 75,000 shares Expires 2031-03-02 F1 · kind: This option grant was previously reported on a Form 8-K filed by the issuer on March 8, 2021. F2 · derivative.exercise_date: These share options vest in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period. Read SEC document |
| March 16, 2019 Filed Oct 8, 2019 20:22 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | GrantShare Options (right to buy) · Derivative | 90,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001567619-19-019350 · doc1.xml · derivative · entry 2 TIMOTHY WRENDON · CIK 0001603598 · Controller & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Ordinary Shares · 90,000 shares Expires 2029-03-16 F1 · kind: This option grant was previously reported on a Form 8-K filed by the issuer on March 21, 2019. F2 · derivative.exercise_date: These share options vest in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period. Read SEC document |
| January 20, 2017 Filed Mar 21, 2017 18:36 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | GrantShare Options (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.06 | $0.00 |
DisclosureSEC source: 0001140361-17-012831 · doc1.xml · derivative · entry 2 TIMOTHY WRENDON · CIK 0001603598 · Controller & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2027-01-20 F1 · derivative.exercise_date: These share options vest in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.